Regulation and function of Growth Differentiation Factor 11 during development and aging

生长分化因子11在发育和衰老过程中的调节和功能

基本信息

  • 批准号:
    9045972
  • 负责人:
  • 金额:
    $ 33.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-15 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Healthy skeletal muscle is essential to sustain normal physical function, and undergoes multiple developmental and functional transitions during fetal, neonatal and adult life. In the latest stages of life, impaired muscle homeostasis and reduced muscle regenerative potential leads to progressive loss of muscle mass and strength. Importantly, reduced muscle function in elderly individuals is one of the strongest predictors of imminent mortality, suggesting that improved understanding of the fundamental mechanisms underlying muscle aging and the development of novel strategies to intervene in this process, would have tremendous impact on lifespan and quality of life of the growing population of aged individuals experiencing degenerative muscle decline. This project focuses on a novel candidate regulator of muscle health throughout life. Our extensive preliminary data indicate that the small circulating hormone Growth Differentiation Factor 11 (GDF11, also known as Bone Morphogenic Protein 11, or BMP11) plays a profound role in modulating the homeostatic remodeling of skeletal muscle fibers and the regenerative activity of muscle stem cells (also known as satellite cells) at particular stages of life. In particular, analysis of GDF11 knockout mice indicates an essential role for this factor in normal development of the axial skeletal and endocrine and nervous system. Although its role in post-natal tissues has only recently begun to be explored, GDF11 protein circulates at high levels in neonatal and young adult animals, but declines dramatically with advancing age and in concert with the emergence of multiple age-associated pathologies in skeletal muscle, as well as cardiac and neural tissue. Excitingly, new data from our published and submitted manuscripts indicate that raising the levels of circulating GDF11 in aged mice can produce a striking reversal of age-related pathologies, including reversal of cardiac hypertrophy, recovery of satellite cell numbers and restoration of muscle regenerative potential. In this project, we will answer questions crucial to understanding the regulation and activity of this new hormone and its potential for regulating developmental and aging phenotypes in mice and humans by: (1) defining the cellular source(s) of circulating GDF11 throughout life and clarifying the basis for its age-dependent decline, (2) evaluating the impact on development and homeostasis of removal of GDF11 at discrete stages of life, and (3) assessing age-regulated changes in GDF11 abundance and function in human tissue and sera. Together, these studies will provide critical insights into muscle developmental biology and aging and may validate a promising candidate therapeutic for the reversal of age-related skeletal muscle dysfunction.
描述(由申请人提供):健康的骨骼肌对于维持正常的身体机能至关重要,并且在胎儿,新生儿和成人生活期间经历多次发育和功能过渡。在生活的最新阶段,肌肉稳态受损和肌肉再生潜力降低会导致肌肉质量和力量的逐渐丧失。重要的是,老年人的肌肉功能降低是即将死亡的最强预测指标之一,这表明对肌肉衰老的基本机制的理解以及介入这一过程的新型策略的发展将对寿命和衰老的生活质量产生巨大影响。该项目着重于一生中新型肌肉健康的候选监管者。我们广泛的初步数据表明,小循环激素生长分化因子11(GDF11,也称为骨形态形态蛋白11或BMP11)在调节骨骼肌纤维的稳态重塑中起着重要作用,在特定阶段的肌肉干细胞(也称为肌肉干细胞)(也称为肌肉干细胞的再生活性)。特别是,对GDF11敲除小鼠的分析表明,该因素在轴向骨骼和内分泌系统正常发育中的重要作用。尽管其在产后组织中的作用最近才开始探索,但GDF11蛋白在新生儿和成年动物的高水平循环中循环,但随着年龄的增长,与骨骼肌以及心脏和神经组织的多个年龄相关病理的出现急剧下降。令人兴奋的是,来自我们已发表和提交的手稿的新数据表明,老年小鼠中循环GDF11的水平可以产生与年龄相关的病理学的惊人逆转,包括心脏肥大的逆转,卫星细胞的恢复和肌肉再生潜力的恢复。在该项目中,我们将回答有关理解这种新激素的调节和活动至关重要的问题,及其在小鼠和人类中调节发育和衰老表型的潜力:(1)定义循环GDF11的细胞来源(S)在整个生命中的循环源,并阐明其与年龄相关的衰落的基础,以评估其依赖于发展的发展,(2)评估其持续性的影响,(2)裁员的持续性,GAD的持续效果是裁定的,GD F. RESS of dist of the Idal of Servue of the Idal of the gy of the p.11 (3)评估人体组织和血清中GDF11丰度和功能的年龄调节变化。这些研究将共同​​提供对肌肉发育生物学和衰老的关键见解,并可以验证有前途的候选治疗方法,以逆转与年龄相关的骨骼肌功能障碍。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMY JO WAGERS其他文献

AMY JO WAGERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMY JO WAGERS', 18)}}的其他基金

Uncovering molecular effectors of mammalian aging
揭示哺乳动物衰老的分子效应因素
  • 批准号:
    10213650
  • 财政年份:
    2018
  • 资助金额:
    $ 33.8万
  • 项目类别:
Uncovering molecular effectors of mammalian aging
揭示哺乳动物衰老的分子效应因素
  • 批准号:
    10441363
  • 财政年份:
    2018
  • 资助金额:
    $ 33.8万
  • 项目类别:
Uncovering molecular effectors of mammalian aging
揭示哺乳动物衰老的分子效应因素
  • 批准号:
    9788219
  • 财政年份:
    2018
  • 资助金额:
    $ 33.8万
  • 项目类别:
Investigating GDF11 and MSTN as candidate circulating geronic factors
研究 GDF11 和 MSTN 作为候选循环老年因子
  • 批准号:
    9421907
  • 财政年份:
    2017
  • 资助金额:
    $ 33.8万
  • 项目类别:
Regulation and Function of Growth Differentiation Factor 11 During Development and Aging
生长分化因子11在发育和衰老过程中的调控和功能
  • 批准号:
    9392347
  • 财政年份:
    2016
  • 资助金额:
    $ 33.8万
  • 项目类别:
Regulation and function of Growth Differentiation Factor 11 during development and aging
生长分化因子11在发育和衰老过程中的调节和功能
  • 批准号:
    9105913
  • 财政年份:
    2016
  • 资助金额:
    $ 33.8万
  • 项目类别:
Regulation and function of Growth Differentiation Factor 11 during development and aging
生长分化因子11在发育和衰老过程中的调节和功能
  • 批准号:
    9886169
  • 财政年份:
    2016
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epigenomic drivers of human muscle progenitor cells in development and disease
人类肌肉祖细胞发育和疾病的表观基因组驱动因素
  • 批准号:
    8814714
  • 财政年份:
    2014
  • 资助金额:
    $ 33.8万
  • 项目类别:
Control of HSC proliferation and migration by the transcription factor EGR1
转录因子 EGR1 控制 HSC 增殖和迁移
  • 批准号:
    8386665
  • 财政年份:
    2009
  • 资助金额:
    $ 33.8万
  • 项目类别:
Control of HSC proliferation and migration by the transcription factor EGR1
转录因子 EGR1 控制 HSC 增殖和迁移
  • 批准号:
    7996588
  • 财政年份:
    2009
  • 资助金额:
    $ 33.8万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

RP4 LEAP
RP4飞跃
  • 批准号:
    10595904
  • 财政年份:
    2023
  • 资助金额:
    $ 33.8万
  • 项目类别:
RP5 MPT Study
RP5 MPT 研究
  • 批准号:
    10595905
  • 财政年份:
    2023
  • 资助金额:
    $ 33.8万
  • 项目类别:
Sleep and Cardiometabolic Subgroup Discovery and Risk Prediction in United States Adolescents and Young Adults: A Multi-Study Multi-Domain Analysis of NHANES and NSRR
美国青少年和年轻人的睡眠和心脏代谢亚组发现和风险预测:NHANES 和 NSRR 的多研究多领域分析
  • 批准号:
    10639360
  • 财政年份:
    2023
  • 资助金额:
    $ 33.8万
  • 项目类别:
Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions
青少年神经发生和中风后恢复的机制:确定与年龄相关的神经免疫相互作用的作用
  • 批准号:
    10637874
  • 财政年份:
    2023
  • 资助金额:
    $ 33.8万
  • 项目类别:
Brain Mechanisms Underlying Changes in Neural Oscillations through Adolescent Cognitive Maturation
青少年认知成熟导致神经振荡变化的大脑机制
  • 批准号:
    10675169
  • 财政年份:
    2023
  • 资助金额:
    $ 33.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了